학술논문
Met gene amplification and protein hyperactivation is a mechanism of resistance to both first and third generation EGFR inhibitors in lung cancer treatment
Document Type
Article
Author
Source
In Cancer Letters 1 October 2016 380(2):494-504
Subject
Language
ISSN
0304-3835